Reports have also indicated that the CXCL17-GPR35 axis can activate the IL-17 signaling pathway, enhancing the viability of colorectal cancer cells, promoting their migration and invasion, and thus increasing resistance to colorectal cancer [54]. This evidence concerns the gene CXCL17 and colorectal cancer.